Skip to main content

Table 3 Online self-report instruments for GAD, panic disorder and agoraphobia, social phobia, specific phobia, OCD and PTSD, and the number of studies that report psychometric characteristics (between parentheses)

From: Validation of online psychometric instruments for common mental health disorders: a systematic review

Instrument

Purpose

N studies

Population/setting

Countries in which the studies were conducted

Internal consistency (alpha)

Test-retest reliability

Factor structure

Mean score difference with paper version

Convergent validity

Criterion validity (AUC)

GAD

          

  GAD-1

Screening

1

G1

NL

     

.78 (1)

  GAD-2

Screening

1

G1

NL

     

.76 (1)

  GAD-7

Screening & symptom severity

1

G1

NL

.86 (1)

 

1 factor (1)

 

(1)

.77 (1)

  GAD-7 BSL

Symptom severity

1

P6

UK

.88 (1)

 

1 factor (1)

 

(1)

 

  PDI GAD

Diagnosis & screening

1

P1

US

    

(1)

(1)

Panic disorder and agoraphobia

          

  ACQ

Symptom severity

2

G1

AU, SE

.81–.84 (2)

  

None, lower (2)

  

  BSQ

Symptom severity

2

G1

AU, SE

.84–.86 (2)

  

None, lower (2)

  

  CIDI-Panic subscale

Diagnosis & screening

1

G1

SE

     

(1)

  MI

Symptom severity

2

G1

AU, SE

.94–.97 (2)

  

None, higher (2)

  

  PDSS-SR item 4

Screening

1

G1

NL

     

.68 (1)

  PDSS-SR item 5

Screening

1

G1

NL

     

.61 (1)

  VS-CMD-agoraphobia

Screening

1

G1

NL

     

.73 (1)

Social phobia

          

  LSAS-SR

Symptom severity

2

G1, P3

SE

.93–.94 (2)

  

None (1)

  

  SIAS

Symptom severity

3

G5, P3

SE, US

.86–.93 (3)

 

1 factor (1)

None (2)

(2)

 

  SPIN

Symptom severity

1

G1

TW

.94 (1)

(1)

3 factors (1)

  

.87 (1)

  SPS

Symptom severity

2

G5, P3

SE, US

.89–.93 (2)

 

1 factor (1)

None (2)

(1)

 

Specific phobia (aviophobia)

          

  FAS

Screening & symptom severity

1

G1 + G5

US

.94–.99 (1)

    

.99 (1)

OCD

          

  C-FOCI

Screening

1

G4

US

.73 (1)

     

  OBQ-44

Symptom severity

1

G5

US

.97 (1)

  

None (1)

(1)

 

  OCI

Symptom severity

1

G5

US

.94 (1)

  

None (1)

(1)

 

  PI

Symptom severity

1

G1

US (mainly)

  

4 factors (1)

   

PTSD

          

  NSES

Diagnosis & symptom severity

1

G1, G7

US

  

4 factors (1)

   

  PCL-C

Symptom severity

1

G5

US

.91 (1)

  

None (1)

  

  PSS

Screening & symptom severity

1

G5

US

.92–.94 (1)

 

4 factors (1)

 

(1)

 

  TSS

Symptom severity

1

G5

US

.95–.96 (1)

  

None (1)

  

  PTSD (peripartum)

          

    PPQ (modified)

Screening & symptom severity

1

G2

US

.90 (1)

 

3 factors (1)

 

(1)

(1)

  1. G1: General population; G2: Adult females; G3: Adult males; G4: General teenage population; G5: Student population; G6: General young adult population; G7: Veteran population; P1: Patient population; P2: Adult psychiatric outpatients; P3: Adult social phobia patients; P4: Adult GP patients; P5: Hearing impaired clinical population; P6: Deaf population; P7: Adults with chronic fatigue syndrome; P8: Participants in studies of the Centre for Addiction and Mental Health; AU: Australia; CA: Canada; DK: Denmark; ES: Spain; NL: Netherlands; NO: Norway; NZ: New Zealand; SE: Sweden; TW: Taiwan; UK: United Kingdom; US: United States; AUC: Area Under the Receiver Operating Characteristic Curve